Freenome 005: Colorectal Cancer Screening Study
Colorectal cancer is the second deadliest form of cancer1. Your participation in the Freenome 005 study will help develop tests to catch cancers in their most effectively treatable stages.
Study Snapshot
Freenome 005 - Colorectal Cancer Screening Early Detection
Purpose:
The goal of the Freenome 005 study is to develop a blood test for future generations that will detect advanced adenomas and colorectal cancer in its earliest, most treatable stages.. The study is sponsored by Freenome.
Eligibility:
The study will enroll approximately 40,000 participants across a range of racial, ethnic, and socioeconomic backgrounds.
Study Population: Participants aged between 45 and 85 who are eligible for CRC screening and scheduled for a standard-of-care screening colonoscopy.
Key Inclusion Criteria
- 45-85 years of age
- Willing to undergo a standard-of-care screening colonoscopy
- Able and willing to provide a blood sample
- Able and willing to sign informed consent
Participation:
Participation is as simple as providing a standard blood draw, (we will arrange for this to be done by a phlebotomist in the convenience and privacy of your own home), shortly before or after your colonoscopy depending on your eligibility classification.
Compensation:
Participants will receive up to $100 for their time after completing their participation in the study.
Participating is simple
1Chat with a Study Coordinator
A brief phone conversation with one of our study coordinators will quickly determine if you meet the eligibility criteria for the study.
2Review and Sign an Informed Consent Form
If you meet the eligibility requirements, the coordinator will guide you through the Informed Consent answering any questions you may have.
3Schedule and Complete Your Blood Draw
You will need to have a standard blood draw - which we will arrange to be done by a phlebotomist in the convenience of your home or office.
4Attend Your Colonoscopy, (if applicable), as Scheduled
For those participating in pre-colonoscopy screening, you’ll simply attend your appointment as scheduled.
We are committed to empowering patients and clinicians to participate in making clinical research more accessible, inclusive and impactful.
Frequently Asked Questions
Who is Aton Health?
What is the relationship between Aton Health and my physician?
Why does my participation matter?
Let's Talk
Just a tiny amount of your time could make a big difference.
Click the link below to schedule a brief call with a study coordinator.
Find a convenient time for a brief call.
AH-005-GH-007-4-25
Copyright 2025, Aton Holdings, Inc.